Skip to content Skip to site index

search

Biotech Hub

Eli Lilly Bets $6.5 Billion on Houston in Weight-Loss Drug Race

Eli Lilly bets $6.5B on Houston in weight-loss drug race

Oral Ozempic alternative inspired biggest biotech investment in Texas history

InterVenn Biosciences' Aldo Carrascoso and rendering of building at 499 Forbes Blvd (Woods Bagot, InterVenn Biosciences, iStock)

Biotech startup takes entire spec development in South SF

InterVenn Biosciences, fueled by $201M Series C fundraise, grows into R&D space

Bell Partners president and ceo Lili F. Dunn with renderings of Cadence Apartments at 400 Cypress Avenue in South San Francisco (Chet Frohlich, Bell Partners Inc.)

Builder sells 260-unit apartment complex in South San Francisco

North Carolina firm pays $206M for one of the few multifamily projects around biotech hub

The Latest